BILLIONTOONE INC CL A
BLLNNASDAQTrading Snapshot
- Day Range
- $97.45 – $98.48
- 52-Week Range
- $61.96 – $150.44
- Volume
- $2.42B
- Avg Volume
- $1.90B
- Shares Outstanding
- 46.0M
- Next Earnings
- Oct 4, 2026
Fundamentals Snapshot
- Annual Revenue
- $305M
- Last Q Revenue
- $109M
- P/E Ratio
- 123.4
- P/S Ratio
- 11.7x
- EPS (TTM)
- $0.77
- Dividend Yield
- —
Why Investors Own BLLN
- ✓High-growth profile — revenue up +23.0% YoY with expanding US Equity exposure.
- ✓Healthy economics — 77% gross margin and 18% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About BILLIONTOONE INC CL A
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
BillionToOne: A Softer Quarter After Heightened Expectations
Top stock movements in today's session.
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top gainers and losers in today's session.
Let's uncover which stocks are experiencing notable gaps during today's session.
Traders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps.
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday's regular session. The company's market cap stands at $4.3 million. Ensysce Biosciences (NASDAQ:ENSC) stock rose
Which stocks are moving before the opening bell on Thursday?
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.